๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Total serum homocysteine in senile dementia of Alzheimer type

โœ Scribed by Andrew McCaddon; Gareth Davies; Peter Hudson; Stephen Tandy; Howard Cattell


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
129 KB
Volume
13
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

โœฆ Synopsis


Objective. The main hypothesis was that subtle vitamin B12 deยฎciencies occur more commonly in senile dementia of Alzheimer type (SDAT) than in healthy elderly individuals, and may be revealed by elevated total serum homocysteine (tHcy). A subsidiary hypothesis was that such deยฎciencies would be nutritionally independent as determined by retinol binding protein (RBP).

Design. A prospective case-controlled survey.

Setting. A Welsh urban psychogeriatric assessment centre and local general practice.

Patients. Thirty patients, aged 65 or over, seen consecutively in 1994 with features compatible with DSM-III-R criteria for primary degenerative dementia of Alzheimer type and 30 cognitively intact age-matched control subjects.

Measures. Diagnosis was assessed using the CAMDEX. Cognitive scores were evaluated with the CAMCOG scale for patients and MMSE scores for control subjects. tHcy was measured using high performance liquid chromatography (HPLC), and RBP assayed by a radial immunodiusion method.

Results. Patients had a highly signiยฎcant elevation of tHcy compared with controls (p 5 0.0001). Multiple regression highlighted the interrelated eects of tHcy and total serum cobalamin on cognitive scores. RBP did not dier between groups. Macrocytosis was absent, and neutrophil hypersegmentation uncommon, in hyperhomocysteinaemic patients.

Conclusions. SDAT patients have signiยฎcantly elevated tHcy. This is independent of RBP determined nutritional status. `Classical' haematological changes of cobalamin or folate deยฎciency are poor predictors of tHcy in these patients. Aberrant cobalamin tissue delivery appears to contribute to SDAT cognitive decline. Relative contributions of other tHcy determinants require further investigation.


๐Ÿ“œ SIMILAR VOLUMES


Cerebrospinal fluid acetylcholinesterase
โœ Dr Larry Tune; Stephen Gucker; Marshal Folstein; Leslie Oshida; Joseph T. Coyle ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 273 KB ๐Ÿ‘ 1 views

Acetylcholinesterase (AChE) activity was measured in cerebrospinal fluid (CSF) samples from 36 individuals, including 12 persons with Alzheimer's disease, 12 normal controls, and 12 patients with other dementias. AChE activity also was measured in 47 normal subjects whose ages ranged from 20 to 84 t

Mild senile dementia of the Alzheimer ty
โœ Dr Leonared Berg; Deborah S. Smith; John C. Morris; J. Philip Miller; Eugene H. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 444 KB

## Abstract Sixtyโ€six subjects diagnosed by validated criteria as having senile dementia of the Alzheimer type (SDAT) were assessed with clinical measures commonly used to study dementia. The severity of the SDAT was mild in 24, moderate in 24, and severe in 18. The data from these three groups in

PROTON MAGNETIC RESONANCE SPECTROSCOPY I
โœ REINHARD HEUN; SABINE SCHLEGEL; MECHTHILD GRAF-MORGENSTERN; JAROSLAV TINTERA; JO ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 197 KB ๐Ÿ‘ 1 views

Reduced N-acetyl aspartate (NAA) and increased myo-inositol (MI) levels have been reported in patients with dementia of Alzheimer type (DAT) in comparison with controls. We wished to assess the validity of these findings and to evaluate possible correlations of metabolite proportions with cognitive